121 related articles for article (PubMed ID: 22202492)
1. Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins.
Vainio P; Lehtinen L; Mirtti T; Hilvo M; Seppänen-Laakso T; Virtanen J; Sankila A; Nordling S; Lundin J; Rannikko A; Orešič M; Kallioniemi O; Iljin K
Oncotarget; 2011 Dec; 2(12):1176-90. PubMed ID: 22202492
[TBL] [Abstract][Full Text] [Related]
2. Combination of theoretical analysis and experiments: Exploring the role of
Xie J; Zhu L; Yang X; Yu F; Fan B; Wu Y; Zhou Z; Lin W; Yang Y
Heliyon; 2024 Mar; 10(6):e27906. PubMed ID: 38509948
[TBL] [Abstract][Full Text] [Related]
3. Are statins onco- suppressive agents for every type of tumor? A systematic review of literature.
Filaferro L; Zaccarelli F; Niccolini GF; Colizza A; Zoccali F; Grasso M; Fusconi M
Expert Rev Anticancer Ther; 2024 Jun; 24(6):435-445. PubMed ID: 38609343
[TBL] [Abstract][Full Text] [Related]
4.
Lehtinen L; Vainio P; Wikman H; Huhtala H; Mueller V; Kallioniemi A; Pantel K; Kronqvist P; Kallioniemi O; Carpèn O; Iljin K
J Pathol Clin Res; 2017 Apr; 3(2):123-138. PubMed ID: 28451461
[TBL] [Abstract][Full Text] [Related]
5. Monocyte-derived factors including PLA2G7 induced by macrophage-nasopharyngeal carcinoma cell interaction promote tumor cell invasiveness.
Low HB; Png CW; Li C; Wang Y; Wong SB; Zhang Y
Oncotarget; 2016 Aug; 7(34):55473-55490. PubMed ID: 27487154
[TBL] [Abstract][Full Text] [Related]
6. Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders.
Deng H; Li W
Acta Pharm Sin B; 2020 Apr; 10(4):582-602. PubMed ID: 32322464
[TBL] [Abstract][Full Text] [Related]
7. Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy.
Morigny P; Kaltenecker D; Zuber J; Machado J; Mehr L; Tsokanos FF; Kuzi H; Hermann CD; Voelkl M; Monogarov G; Springfeld C; Laurent V; Engelmann B; Friess H; Zörnig I; Krüger A; Krijgsveld J; Prokopchuk O; Fisker Schmidt S; Rohm M; Herzig S; Berriel Diaz M
J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1333-1351. PubMed ID: 34427055
[TBL] [Abstract][Full Text] [Related]
8. Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma.
Zheng W; Lin Q; Issah MA; Liao Z; Shen J
BMC Cancer; 2021 Aug; 21(1):927. PubMed ID: 34404374
[TBL] [Abstract][Full Text] [Related]
9. Comparison of serum acetyl hydrolase (PAF-AH) and paraoxonase 1 (PON1) values between prostate cancer patients and a control group.
Benli E; Bayrak A; Cirakoglu A; Bayrak T; Noyan T
Kaohsiung J Med Sci; 2017 Nov; 33(11):572-577. PubMed ID: 29050675
[TBL] [Abstract][Full Text] [Related]
10. Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.
Alinezhad S; Väänänen RM; Mattsson J; Li Y; Tallgrén T; Tong Ochoa N; Bjartell A; Åkerfelt M; Taimen P; Boström PJ; Pettersson K; Nees M
PLoS One; 2016; 11(5):e0155901. PubMed ID: 27196083
[TBL] [Abstract][Full Text] [Related]
11. Blood mRNA expression profiling predicts survival in patients treated with tremelimumab.
Saenger Y; Magidson J; Liaw B; de Moll E; Harcharik S; Fu Y; Wassmann K; Fisher D; Kirkwood J; Oh WK; Friedlander P
Clin Cancer Res; 2014 Jun; 20(12):3310-8. PubMed ID: 24721645
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of phospholipase A2 group 7 decreases intestinal polyposis and colon tumorigenesis in Apc(Min/+) mice.
Xu C; Reichert EC; Nakano T; Lohse M; Gardner AA; Revelo MP; Topham MK; Stafforini DM
Cancer Res; 2013 May; 73(9):2806-16. PubMed ID: 23361301
[TBL] [Abstract][Full Text] [Related]
13. Phospholipase PLA2G7 is complementary to GPX4 in mitigating punicic-acid-induced ferroptosis in prostate cancer cells.
Vermonden P; Martin M; Glowacka K; Neefs I; Ecker J; Höring M; Liebisch G; Debier C; Feron O; Larondelle Y
iScience; 2024 May; 27(5):109774. PubMed ID: 38711443
[TBL] [Abstract][Full Text] [Related]
14. Co-inhibition of TGF-β and PD-L1 pathways in a metastatic colorectal cancer mouse model triggers interferon responses, innate cells and T cells, alongside metabolic changes and tumor resistance.
Nair R; Lannagan TRM; Jackstadt R; Andrusaite A; Cole J; Boyne C; Nibbs RJB; Sansom OJ; Milling S
Oncoimmunology; 2024; 13(1):2330194. PubMed ID: 38516270
[TBL] [Abstract][Full Text] [Related]
15. The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism.
Oh M; Jang SY; Lee JY; Kim JW; Jung Y; Kim J; Seo J; Han TS; Jang E; Son HY; Kim D; Kim MW; Park JS; Song KH; Oh KJ; Kim WK; Bae KH; Huh YM; Kim SH; Kim D; Han BS; Lee SC; Hwang GS; Lee EW
Nat Commun; 2023 Sep; 14(1):5728. PubMed ID: 37714840
[TBL] [Abstract][Full Text] [Related]
16. Investigating the potential mechanism of quercetin against cervical cancer.
Chu M; Ji H; Li K; Liu H; Peng M; Wang Z; Zhu X
Discov Oncol; 2023 Sep; 14(1):170. PubMed ID: 37704909
[TBL] [Abstract][Full Text] [Related]
17. Proteomics biomarker discovery for individualized prevention of familial pancreatic cancer using statistical learning.
Ha CSR; Müller-Nurasyid M; Petrera A; Hauck SM; Marini F; Bartsch DK; Slater EP; Strauch K
PLoS One; 2023; 18(1):e0280399. PubMed ID: 36701413
[TBL] [Abstract][Full Text] [Related]
18. PLA2G7/PAF-AH as Potential Negative Regulator of the Wnt Signaling Pathway Mediates Protective Effects in BRCA1 Mutant Breast Cancer.
Liao Y; Badmann S; Kraus F; Topalov NE; Mayr D; Kolben T; Hester A; Beyer S; Mahner S; Jeschke U; Trillsch F; Czogalla B; Burges A
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614323
[TBL] [Abstract][Full Text] [Related]
19. LINC01094 Predicts Poor Prognosis in Patients With Gastric Cancer and is Correlated With EMT and Macrophage Infiltration.
Ye Y; Ge O; Zang C; Yu L; Eucker J; Chen Y
Technol Cancer Res Treat; 2022; 21():15330338221080977. PubMed ID: 35254147
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
